FY25 consensus $582.06M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- Buy Rating for TransMedics Group Amid Strong Q2 Prospects and Seasonal Challenges
- Cautious Optimism for TransMedics Group Amid Strong Growth Indicators
- TransMedics Group: Strong Market Position and Ethical Practices Justify Buy Rating Amid Controversies
- TransMedics price target raised to $142 from $129 at Canaccord
- Strong Financial Outlook: TransMedics Group’s Surpassing Sales and EPS Forecasts